MedPath

Changes of Functional Connectivity After rTMS in Depression

Phase 4
Completed
Conditions
Major Depression
Interventions
Device: repetitive transcranial magnetic stimulation(rTMS)
Device: Sham repetitive transcranial magnetic stimulation(rTMS)
Registration Number
NCT01325831
Lead Sponsor
Yonsei University
Brief Summary

In order to explore the effect of repetitive TMS, which has shown to be effective in intractable depression, we will examine resting-state, default-mode network functional connectivity in patients with major depression. We will use a double-blind, sham-controlled design. Our target sample size is 60(30 patients will be treated by active rTMS, the other 30 will be treated by sham rTMS). We will apply 10-day course of 10 Hz rTMS on left dorsolateral prefrontal cortex of the subjects.

Detailed Description

Up to now, 24 patients with major depression and 6 normal controls are enrolled. Twenty-three patients and 4 normal participants have taken 10 days rTMS. One patients and one control withdrew their consent without any reason and one control withdrew the consent because of headache.

We scanned fMRIs(to examine functional connectivity)twice for each participant, which were taken 3 days before the first and 3 days after the last rTMS.

All of participants have not reported side effects except mild headahe. There's been no seizure event up to now.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • DSM-IV major depressive episode
  • Failure of at least 3 different kind of antidepressant
Exclusion Criteria
  • Organic brain disorder
  • Other diagnosis of DMS-IV except nicotine dependence
  • History of seizure disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
transcranial magnetic stimluationrepetitive transcranial magnetic stimulation(rTMS)-
rTMS_shamSham repetitive transcranial magnetic stimulation(rTMS)-
Primary Outcome Measures
NameTimeMethod
change of functional connectivity between pre/post rTMS14 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Psychiatry, Severance Hospital

🇰🇷

Seoul,, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath